What is King Pharmaceuticals's workers' compensation — year 4?

King Pharmaceuticals (KG) reported workers' compensation — year 4 of 8.9% in Q4 2025.

What does workers' compensation — year 4 mean?

This metric represents the total revenue or financial performance attributed to the Workers' Compensation insurance product line during the fourth year of the reporting period. It reflects the company's ability to underwrite and manage risk within this specific segment of the commercial insurance market.

King Pharmaceuticals KG Workers' Compensation — Year 4

Other product segments

Commercial Auto Liability

18.2%—

General Liability

15.9%—

European Hospital Liability

13.7%—

All other lines

4.7%—

International

-0.3%—

Similar metrics at other companies

CNAWorkers' Compensation — Year 4

8.8%0.0pp

ORIWorkers' Compensation — Year 4

8.1%-0.2pp

UFCSCommercial workers' compensation — Year 4

8.2%+0.3pp

HIGWorkers' Compensation — 4th Year

8.3%+0.2pp

CINFWorkers' Compensation Line — 4

6.5%-0.2pp

CNAWorkers' Compensation — Workers' Compensation

-$33.75M+33.2%

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's workers' compensation — year 4.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's workers' compensation — year 4?: King Pharmaceuticals (KG) reported workers' compensation — year 4 of 8.9% in Q4 2025.
What does workers' compensation — year 4 mean?: This metric represents the total revenue or financial performance attributed to the Workers' Compensation insurance product line during the fourth year of the reporting period. It reflects the company's ability to underwrite and manage risk within this specific segment of the commercial insurance market.